Author: Willemsen, Anouk; Zwart, Mark P
Title: On the stability of sequences inserted into viral genomes Document date: 2019_11_14
ID: vv5gpldi_69
Snippet: Besides the risks related to retroviral gene therapy, the limited efficiency of in vivo gene transfer poses another obstacle. Replication defective retrovirus vectors are often used in clinical trials but limited since they can only infect a fraction of solid tumor cells (Rainov and Ren 2003) . For the delivery of the transgene in all tumor cells, replication-competent retroviral vectors are a promising alternative. The suitability of murine leuk.....
Document: Besides the risks related to retroviral gene therapy, the limited efficiency of in vivo gene transfer poses another obstacle. Replication defective retrovirus vectors are often used in clinical trials but limited since they can only infect a fraction of solid tumor cells (Rainov and Ren 2003) . For the delivery of the transgene in all tumor cells, replication-competent retroviral vectors are a promising alternative. The suitability of murine leukemia virus (MLV)-based vectors for cancer gene therapy has been analyzed in vitro and in vivo by Paar et al. (2007) . They found that the choice of the virus strain, the position of the insert, and the host cells used, can influence the replication kinetics, genomic stability, and transgene expression levels (Paar et al. 2007) .
Search related documents:
Co phrase search for related documents- cancer gene therapy and gene transfer: 1, 2, 3, 4
- cancer gene therapy and host cell: 1
- cancer gene therapy vector and gene therapy: 1
- clinical trial and gene therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- clinical trial and gene transfer: 1
- clinical trial and genomic stability: 1
- clinical trial and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- clinical trial and leukemia virus: 1
- clinical trial and limited efficiency: 1
- clinical trial and promising alternative: 1, 2, 3
- gene therapy and genomic stability: 1, 2
- gene therapy and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- gene therapy and insert position: 1
- gene therapy and leukemia virus: 1, 2
- gene therapy and murine leukemia virus: 1
- gene therapy and promising alternative: 1, 2
- gene transfer and limited efficiency: 1, 2
- gene transfer and murine leukemia virus: 1
- gene transfer and promising alternative: 1, 2
Co phrase search for related documents, hyperlinks ordered by date